Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Filtrate vs FMT in Recurrent CDI
NCT04960306Phase 3Not yet recruiting
- Sponsor
- University of Pécs
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of fecal filtrate in Clostridioides difficile infection (CDI), sponsored by University of Pécs. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
fecal filtrate
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT04960306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04960306.